About Us Redefining Expectations in Rare Diseases Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. We believe that breakthroughs are possible. That is why we push ideas as far and as fast as possible – […]